SCHEMBL3237068

SCHEMBL3237068

COc1ccc2c(c1)C(c1ccccc1)N(C(=O)CCC(=O)O)CC2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.58
▸ LMNA P02545 2/20 0.58
▸ NPC1 O15118 1/20 0.58
▸ MITF O75030 1/20 0.58
▸ XBP1 P17861 1/20 0.58
▸ HTT P42858 1/20 0.58
▸ RAB9A P51151 1/20 0.58
▸ NPSR1 Q6W5P4 1/20 0.58
▸ L3MBTL1 Q9Y468 1/20 0.57
▸ MTNR1B P49286 2/20 0.56
▸ MTNR1A P48039 1/20 0.56
▸ TAS2R14 Q9NYV8 2/20 0.55
▸ TRPV1 Q8NER1 1/20 0.55
▸ CA1 P00915 2/20 0.52
▸ CA2 P00918 2/20 0.52
▸ CA9 Q16790 2/20 0.52
▸ CA14 Q9ULX7 2/20 0.52
▸ CA12 O43570 1/20 0.52
▸ CA7 P43166 1/20 0.52
▸ RORC P51449 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3236426 0.85 LMNA (0.53) ALDH1A1LMNANPC1MITFXBP1
SCHEMBL3234504 0.83 CHRM3 (0.51) ALDH1A1LMNANPC1MITFXBP1
SCHEMBL27841341 0.82 HHAT (0.62) HHATCHRM2CHRM1CHRM3CYP2D6
SCHEMBL12312693 0.81 CYP2D6 (0.75) ALDH1A1LMNANPC1MITFXBP1
SCHEMBL13507980 0.81 CYP2D6 (0.75) ALDH1A1LMNANPC1MITFXBP1
SCHEMBL3244171 0.81 ALDH1A1 (0.49) ALDH1A1LMNANPC1MITFXBP1
SCHEMBL30795608 0.81 ALDH1A1 (0.49) ALDH1A1LMNANPC1MITFXBP1
SCHEMBL3239030 0.79 ALDH1A1 (0.48) ALDH1A1LMNANPC1MITFXBP1
SCHEMBL30794691 0.79 ALDH1A1 (0.48) ALDH1A1LMNANPC1MITFXBP1
SCHEMBL30795254 0.79 USP2 (0.45) ALDH1A1LMNANPC1MITFXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367700-B2 Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2013-02-05 — — US disclosed
US-20100152234-A1 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators GRUNENTHAL GMBH (DE) 2010-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152234-A1 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators KCNAB1, KCNQ2, KCNQ1 ALDH1A1 2801/4885LMNA 2050/4885NPC1 2294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback